Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of driving time, distance, and socioeconomic factors on outcomes of patients with locally advanced rectal cancer.
Gotfrit J, Thangarasa T, Dudani S, Goodwin R, Tang PA, Monzon J, Dennis K, Cheung WY, Marginean H, Vickers M; CHORD Consortium. Gotfrit J, et al. Among authors: monzon j. Public Health Pract (Oxf). 2020 May 24;1:100012. doi: 10.1016/j.puhip.2020.100012. eCollection 2020 Nov. Public Health Pract (Oxf). 2020. PMID: 36101686 Free PMC article.
Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study.
Armstrong D, Raissouni S, Price Hiller J, Mercer J, Powell E, MacLean A, Jiang M, Doll C, Goodwin R, Batuyong E, Zhou K, Monzon JG, Tang PA, Heng DY, Cheung WY, Vickers MM. Armstrong D, et al. Among authors: monzon jg. Clin Colorectal Cancer. 2015 Dec;14(4):291-5. doi: 10.1016/j.clcc.2015.06.001. Epub 2015 Jun 18. Clin Colorectal Cancer. 2015. PMID: 26433487
A multicentre, open-label phase II study of Irinotecan, capecitabine (Xeloda®), and Oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma.
Lui A, Mulder K, Brezden-Masley C, Vickers M, Monzon J, Kennecke H, Goel R, Vos L, Ghosh S, Marginean H, Fields A, Maroun J, Spratlin J. Lui A, et al. Among authors: monzon j. Invest New Drugs. 2018 Aug;36(4):674-682. doi: 10.1007/s10637-018-0599-4. Epub 2018 May 4. Invest New Drugs. 2018. PMID: 29725881 Clinical Trial.
Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials.
Gan CL, Stukalin I, Meyers DE, Dudani S, Grosjean HAI, Dolter S, Ewanchuk BW, Goutam S, Sander M, Wells C, Pabani A, Cheng T, Monzon J, Morris D, Basappa NS, Pal SK, Wood LA, Donskov F, Choueiri TK, Heng DYC. Gan CL, et al. Among authors: monzon j. Eur J Cancer. 2021 Jul;151:115-125. doi: 10.1016/j.ejca.2021.04.004. Epub 2021 May 8. Eur J Cancer. 2021. PMID: 33975059 Free article.
162 results